Impact ledger
AstraZeneca PLC (AZN)
6 events mapped to this ticker since 2026-06-22.
Event impact log
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-07-15 | Event | Increased competition in the oncology market, particularly in NSCLC, from a strengthened GSK pipeline. | watch | 1-5y | 0.30 |
| 2026-06-29 | Event | Increased competition or market dynamics in the COPD market, potential for future M&A activity in the respiratory space. | watch | 3-12m | 0.30 |
| 2026-06-23 | Event | Potential for future competition or collaboration in the lung cancer treatment market, specifically concerning PD-1/PD-L1 inhibitors. | watch | 3-12m | 0.20 |
| 2026-06-22 | Event | Potential future competition or partnership opportunities in the PD-1/PD-L1 inhibitor market for lung cancer. | watch | 3-12m | 0.10 |
| 2026-06-22 | Event | Potential future competition or partnership opportunities in the lung cancer treatment market, specifically concerning PD-1/PD-L1 inhibitors. | watch | 1-5y | 0.10 |
| 2026-06-22 | Event | Potential future competition or partnership opportunities. AstraZeneca has PD-L1 inhibitors like Imfinzi (durvalumab) used in lung cancer. | watch | 1-5y | 0.10 |
This ledger is regenerated from Market Ontology's public event pipeline. For live alerts on new assumption changes for AZN, start a trial or view the AZN entity page.